Effectiveness on the clinical outcome of an oral enterovaccine (Colifagina) and evaluation of the role of the Astrovirus in the aetiology of the pathology of acute gastroenteritis in children.? - ND

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2008年5月28日最近更新: 2012年3月19日

试验速览

暂无简介。

•Patients aged >2 and <10 years old
•Intestine symptoms have been present for at least 24 hours and for less than 3 weeks: diarrhoea (al least 2 evacuations/day) and/or vomit.
•Fever (TC = o > 37.5C).
•Informed consent to study given by parents
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Patients suffering from a present or past neoplastic condition, with chronic renal insufficiency and/or hepatic insufficiency or severe cardiovascular and/or neurological and/or gastrointestinal pathology.
•Patients with congenital deficit of IgA and/or with congenital immuno-deficiency
•Patients receiving immunosuppressive therapy

发起方

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI